Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
130,000,949
-
Share change
-
-1,795,409
-
Total reported value
-
$275,619,530
-
Put/Call ratio
-
16%
-
Price per share
-
$2.12
-
Number of holders
-
181
-
Value change
-
-$14,338,126
-
Number of buys
-
74
-
Number of sells
-
94
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2016
As of 31 Dec 2016,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
130,000,949 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., ACADIAN ASSET MANAGEMENT LLC, MACKENZIE FINANCIAL CORP, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
181
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.